Last reviewed · How we verify

NCT07510178

Retrograde Intrarenal Surgery Versus Extracorporeal Shockwave Lithotripsy

Not yet recruiting NA Last updated 15 April 2026
What this trial tests

NA trial testing Retrograde intrarenal surgery in Renal Stone in 66 participants. Not yet recruiting.

Timeline
30 April 2026
Primary endpoint
30 October 2026
30 October 2026

Quick facts

Lead sponsorSindh Institute of Urology and Transplantation
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment66
Start date30 April 2026
Primary completion30 October 2026
Estimated completion30 October 2026
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Sindh Institute of Urology and Transplantation

Who can join

Adults 18 to 60, any sex, with Renal Stone or Stone in Calyceal Diverticulum. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study's aim is to determine which treatment modality, either ESWL or RIRS, is more effective in achieving stone clearance for lower calyceal calculi. Investigators hypothesize that retrograde intrarenal surgery is better as compared to extracorporeal shockwave lithotripsy. It will target those patients suffering from kidney stones in lower calyces with sizes up to 1.5 cm in an open-label, randomized controlled trial.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Retrograde intrarenal surgery

Trials testing the same drug.

Other recruiting trials for Renal Stone

Currently open trials in the same condition.

Other Sindh Institute of Urology and Transplantation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07510178.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing